June 26 (Reuters) - Neovasc Inc NVCN.TO :
* NEOVASC ANNOUNCES POSITIVE INTERIM RESULTS FROM REDUCER-I STUDY
* NEOVASC- 70% OF PATIENTS SAW IMPROVEMENT IN SYMPTOMS BY AT LEAST 1 CCS CLASS THAT WAS MAINTAINED THROUGH 3 YRS
* NEOVASC- 34% PATIENTS SAW IMPROVEMENT IN SYMPTOMS BY AT LEAST 2 CCS CLASSES THAT WAS MAINTAINED THROUGH 3 YRS
* NEOVASC - LESS THAN 1% OF PATIENTS EXPERIENCED DEVICE OR PROCEDURE RELATED MAJOR ADVERSE EVENT